Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.

@article{Versiani2002ReboxetineAS,
  title={Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.},
  author={M{\'a}rcio C Versiani and Giovanni Battista Cassano and Giulio Perugi and Alessandra Benedetti and Luigia Mastalli and A Joseph Nardi and Mario Savino},
  journal={The Journal of clinical psychiatry},
  year={2002},
  volume={63 1},
  pages={31-7}
}
BACKGROUND Tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs) as well as benzodiazepines have been shown to be effective for the treatment of panic disorder. The introduction of SSRIs has enabled a greater understanding of the role of serotonin in the etiology of panic disorder; however, the role of norepinephrine has been more challenging to ascertain. The aim of this study was to determine the efficacy and tolerability of reboxetine, a novel selective norepinephrine… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

Similar Papers

Loading similar papers…